{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,27]],"date-time":"2026-08-27T05:12:31Z","timestamp":1787807551088,"version":"build-2784847793"},"reference-count":50,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,11,22]],"date-time":"2025-11-22T00:00:00Z","timestamp":1763769600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100008980","name":"Medical College of Wisconsin","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100008980","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["HL139638"],"award-info":[{"award-number":["HL139638"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["HL142578"],"award-info":[{"award-number":["HL142578"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["HL178475"],"award-info":[{"award-number":["HL178475"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["AG084736"],"award-info":[{"award-number":["AG084736"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["celltherapyjournal.org","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cytotherapy"],"published-print":{"date-parts":[[2026,2]]},"DOI":"10.1016\/j.jcyt.2025.102009","type":"journal-article","created":{"date-parts":[[2025,11,22]],"date-time":"2025-11-22T16:12:35Z","timestamp":1763827955000},"page":"102009","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"title":["Implantation of human mesenchymal stromal cell pellet for therapeutic angiogenesis"],"prefix":"10.1016","volume":"28","author":[{"given":"Akiko","family":"Mammoto","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Priscilla","family":"Kyi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0003-1359-9833","authenticated-orcid":false,"given":"Mikaela","family":"Scheer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0002-0985-0856","authenticated-orcid":false,"given":"Tadanori","family":"Mammoto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"10","key":"10.1016\/j.jcyt.2025.102009_bib0001","doi-asserted-by":"crossref","first-page":"1019","DOI":"10.1016\/j.jcyt.2019.08.002","article-title":"Mesenchymal stem versus stromal cells: International Society for Cell & Gene Therapy (ISCT(R)) Mesenchymal Stromal Cell committee position statement on nomenclature","volume":"21","author":"Viswanathan","year":"2019","journal-title":"Cytotherapy"},{"key":"10.1016\/j.jcyt.2025.102009_bib0002","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/j.jare.2024.05.004","article-title":"Mesenchymal stem cell secretome for regenerative medicine: Where do we stand?","volume":"70","author":"Trigo","year":"2025","journal-title":"J Adv Res"},{"issue":"6","key":"10.1016\/j.jcyt.2025.102009_bib0003","doi-asserted-by":"crossref","first-page":"1445","DOI":"10.1002\/sctm.17-0051","article-title":"Mesenchymal Stem Cells: Time to Change the Name!","volume":"6","author":"Caplan","year":"2017","journal-title":"Stem Cells Transl Med"},{"issue":"1","key":"10.1016\/j.jcyt.2025.102009_bib0004","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1007\/s12015-021-10231-w","article-title":"Clinical Trials Based on Mesenchymal Stromal Cells are Exponentially Increasing: Where are We in Recent Years?","volume":"18","author":"Galderisi","year":"2022","journal-title":"Stem Cell Rev Rep"},{"issue":"13","key":"10.1016\/j.jcyt.2025.102009_bib0005","doi-asserted-by":"crossref","first-page":"2925","DOI":"10.3390\/jcm10132925","article-title":"Biodistribution of Mesenchymal Stromal Cells after Administration in Animal Models and Humans: A Systematic Review","volume":"10","author":"Sanchez-Diaz","year":"2021","journal-title":"J Clin Med"},{"issue":"30","key":"10.1016\/j.jcyt.2025.102009_bib0006","doi-asserted-by":"crossref","first-page":"eaba6884","DOI":"10.1126\/sciadv.aba6884","article-title":"Shattering barriers toward clinically meaningful MSC therapies","volume":"6","author":"Levy","year":"2020","journal-title":"Sci Adv"},{"issue":"2","key":"10.1016\/j.jcyt.2025.102009_bib0007","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/j.pharmthera.2014.02.013","article-title":"Mesenchymal stem\/stromal cells as a pharmacological and therapeutic approach to accelerate angiogenesis","volume":"143","author":"Bronckaers","year":"2014","journal-title":"Pharmacol Ther"},{"key":"10.1016\/j.jcyt.2025.102009_bib0008","doi-asserted-by":"crossref","DOI":"10.1155\/2020\/4356359","article-title":"Paracrine Mechanisms of Mesenchymal Stromal Cells in Angiogenesis","volume":"2020","author":"Maacha","year":"2020","journal-title":"Stem Cells Int"},{"issue":"17","key":"10.1016\/j.jcyt.2025.102009_bib0009","doi-asserted-by":"crossref","first-page":"7051","DOI":"10.18632\/aging.102236","article-title":"Effects of age-dependent changes in cell size on endothelial cell proliferation and senescence through YAP1","volume":"11","author":"Mammoto","year":"2019","journal-title":"Aging (Albany NY)"},{"issue":"3","key":"10.1016\/j.jcyt.2025.102009_bib0010","doi-asserted-by":"crossref","first-page":"e36","DOI":"10.4142\/jvs.23300","article-title":"Pulmonary passage of canine adipose tissue-derived mesenchymal stem cells through intravenous transplantation in mouse model","volume":"25","author":"Kwon","year":"2024","journal-title":"J Vet Sci"},{"issue":"14","key":"10.1016\/j.jcyt.2025.102009_bib0011","doi-asserted-by":"crossref","first-page":"7545","DOI":"10.3390\/ijms23147545","article-title":"Can a Scaffold Enriched with Mesenchymal Stem Cells Be a Good Treatment for Spinal Cord Injury?","volume":"23","author":"Blando","year":"2022","journal-title":"Int J Mol Sci"},{"issue":"5","key":"10.1016\/j.jcyt.2025.102009_bib0012","doi-asserted-by":"crossref","first-page":"692","DOI":"10.1016\/j.stem.2022.04.002","article-title":"Biomaterials to enhance stem cell transplantation","volume":"29","author":"Kharbikar","year":"2022","journal-title":"Cell Stem Cell"},{"key":"10.1016\/j.jcyt.2025.102009_bib0013","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1038\/s41536-019-0070-y","article-title":"Proteomic analysis of human mesenchymal stromal cell secretomes: a systematic comparison of the angiogenic potential","volume":"4","author":"Kehl","year":"2019","journal-title":"NPJ Regen Med"},{"issue":"3","key":"10.1016\/j.jcyt.2025.102009_bib0014","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1002\/stem.2298","article-title":"Comprehensive Proteomic Analysis of Mesenchymal Stem Cell Exosomes Reveals Modulation of Angiogenesis via Nuclear Factor-KappaB Signaling","volume":"34","author":"Anderson","year":"2016","journal-title":"Stem Cells"},{"issue":"2","key":"10.1016\/j.jcyt.2025.102009_bib0015","doi-asserted-by":"crossref","first-page":"e949","DOI":"10.1002\/term.2417","article-title":"Unbiased and quantitative proteomics reveals highly increased angiogenesis induction by the secretome of mesenchymal stromal cells isolated from fetal rather than adult skin","volume":"12","author":"Gaetani","year":"2018","journal-title":"J Tissue Eng Regen Med"},{"issue":"1","key":"10.1016\/j.jcyt.2025.102009_bib0016","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1186\/s13287-023-03374-9","article-title":"Recent advances in pre-conditioned mesenchymal stem\/stromal cell (MSCs) therapy in organ failure; a comprehensive review of preclinical studies","volume":"14","author":"Kahrizi","year":"2023","journal-title":"Stem Cell Res Ther"},{"key":"10.1016\/j.jcyt.2025.102009_bib0017","doi-asserted-by":"crossref","DOI":"10.1155\/2016\/3924858","article-title":"Preconditioning of Human Mesenchymal Stem Cells to Enhance Their Regulation of the Immune Response","volume":"2016","author":"Saparov","year":"2016","journal-title":"Stem Cells Int"},{"issue":"3","key":"10.1016\/j.jcyt.2025.102009_bib0018","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1097\/MOH.0b013e3282f97d98","article-title":"Fibroblast growth factor regulation of neovascularization","volume":"15","author":"Murakami","year":"2008","journal-title":"Curr Opin Hematol"},{"issue":"21","key":"10.1016\/j.jcyt.2025.102009_bib0019","doi-asserted-by":"crossref","first-page":"2487","DOI":"10.1161\/01.CIR.0000128595.79378.FA","article-title":"Therapeutic angiogenesis and vasculogenesis for ischemic disease. Part I: angiogenic cytokines","volume":"109","author":"Losordo","year":"2004","journal-title":"Circulation"},{"issue":"1","key":"10.1016\/j.jcyt.2025.102009_bib0020","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1186\/s13036-023-00330-2","article-title":"Therapeutic angiogenesis and tissue revascularization in ischemic vascular disease","volume":"17","author":"Chen","year":"2023","journal-title":"J Biol Eng"},{"issue":"11","key":"10.1016\/j.jcyt.2025.102009_bib0021","doi-asserted-by":"crossref","first-page":"1513","DOI":"10.1089\/hum.2010.165","article-title":"Genetic engineering of mesenchymal stem cells and its application in human disease therapy","volume":"21","author":"Hodgkinson","year":"2010","journal-title":"Hum Gene Ther"},{"key":"10.1016\/j.jcyt.2025.102009_bib0022","doi-asserted-by":"crossref","first-page":"737","DOI":"10.3389\/fcell.2020.00737","article-title":"Genetic Engineering as a Strategy to Improve the Therapeutic Efficacy of Mesenchymal Stem\/Stromal Cells in Regenerative Medicine","volume":"8","author":"Damasceno","year":"2020","journal-title":"Front Cell Dev Biol"},{"issue":"9","key":"10.1016\/j.jcyt.2025.102009_bib0023","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1038\/nrd.2016.278","article-title":"Therapeutic targeting of the angiopoietin-TIE pathway","volume":"16","author":"Saharinen","year":"2017","journal-title":"Nat Rev Drug Discov"},{"issue":"7","key":"10.1016\/j.jcyt.2025.102009_bib0024","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1161\/01.RES.87.7.603","article-title":"Angiopoietin-1 is an antipermeability and anti-inflammatory agent in vitro and targets cell junctions","volume":"87","author":"Gamble","year":"2000","journal-title":"Circ Res"},{"issue":"11-12","key":"10.1016\/j.jcyt.2025.102009_bib0025","doi-asserted-by":"crossref","first-page":"1166","DOI":"10.1080\/10715762.2019.1697809","article-title":"The role of pigment epithelium-derived factor in protecting against cellular stress","volume":"53","author":"Brook","year":"2019","journal-title":"Free Radic Res"},{"issue":"2","key":"10.1016\/j.jcyt.2025.102009_bib0026","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1096\/fj.05-4313fje","article-title":"Pigment epithelium-derived factor (PEDF) is an endogenous antiinflammatory factor","volume":"20","author":"Zhang","year":"2006","journal-title":"FASEB J"},{"issue":"6","key":"10.1016\/j.jcyt.2025.102009_bib0027","doi-asserted-by":"crossref","first-page":"987","DOI":"10.1016\/j.apsb.2020.02.015","article-title":"TIMP1 preserves the blood-brain barrier through interacting with CD63\/integrin \u03b21 complex and regulating downstream FAK\/RhoA signaling","volume":"10","author":"Tang","year":"2020","journal-title":"Acta Pharm Sin B"},{"issue":"6","key":"10.1016\/j.jcyt.2025.102009_bib0028","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1136\/svn-2023-002956","article-title":"TIMP1 protects against blood-brain barrier disruption after subarachnoid haemorrhage by inhibiting ubiquitination of astrocytic \u03b21-integrin","volume":"9","author":"Tang","year":"2024","journal-title":"Stroke Vasc Neurol"},{"issue":"4","key":"10.1016\/j.jcyt.2025.102009_bib0029","doi-asserted-by":"crossref","first-page":"1517","DOI":"10.1016\/j.ajpath.2010.12.031","article-title":"Novel protective properties of IGFBP-3 result in enhanced pericyte ensheathment, reduced microglial activation, increased microglial apoptosis, and neuronal protection after ischemic retinal injury","volume":"178","author":"Kielczewski","year":"2011","journal-title":"Am J Pathol"},{"issue":"9","key":"10.1016\/j.jcyt.2025.102009_bib0030","doi-asserted-by":"crossref","first-page":"897","DOI":"10.1161\/CIRCRESAHA.109.199059","article-title":"Insulin-like growth factor binding protein-3 mediates vascular repair by enhancing nitric oxide generation","volume":"105","author":"Kielczewski","year":"2009","journal-title":"Circ Res"},{"issue":"1","key":"10.1016\/j.jcyt.2025.102009_bib0031","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1093\/stcltm\/szab005","article-title":"Improved MSC Minimal Criteria to Maximize Patient Safety: A Call to Embrace Tissue Factor and Hemocompatibility Assessment of MSC Products","volume":"11","author":"Moll","year":"2022","journal-title":"Stem Cells Transl Med"},{"issue":"1","key":"10.1016\/j.jcyt.2025.102009_bib0032","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1038\/s41392-022-00932-0","article-title":"The secretion profile of mesenchymal stem cells and potential applications in treating human diseases","volume":"7","author":"Han","year":"2022","journal-title":"Signal Transduct Target Ther"},{"issue":"1","key":"10.1016\/j.jcyt.2025.102009_bib0033","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1186\/s13287-023-03381-w","article-title":"MSCs' conditioned media cytokine and growth factor profiles and their impact on macrophage polarization","volume":"14","author":"Peshkova","year":"2023","journal-title":"Stem Cell Res Ther"},{"key":"10.1016\/j.jcyt.2025.102009_bib0034","doi-asserted-by":"crossref","first-page":"24","DOI":"10.3389\/fphys.2016.00024","article-title":"Mesenchymal Stem Cell-Derived Extracellular Vesicles Promote Angiogenesis: Potencial Clinical Application","volume":"7","author":"Merino-Gonzalez","year":"2016","journal-title":"Front Physiol"},{"issue":"1","key":"10.1016\/j.jcyt.2025.102009_bib0035","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1186\/s13287-019-1276-z","article-title":"Therapeutic angiogenesis using stem cell-derived extracellular vesicles: an emerging approach for treatment of ischemic diseases","volume":"10","author":"Bian","year":"2019","journal-title":"Stem Cell Res Ther"},{"issue":"1","key":"10.1016\/j.jcyt.2025.102009_bib0036","first-page":"4","article-title":"Extracellular Vesicles\u2019 Role in Angiogenesis and Altering Angiogenic Signaling","volume":"12","author":"Ateeq","year":"2024","journal-title":"Med Sci (Basel)"},{"issue":"1","key":"10.1016\/j.jcyt.2025.102009_bib0037","doi-asserted-by":"crossref","first-page":"106","DOI":"10.7150\/thno.16911","article-title":"Heparin improves BMSC cell therapy: Anticoagulant treatment by heparin improves the safety and therapeutic effect of bone marrow-derived mesenchymal stem cell cytotherapy","volume":"7","author":"Liao","year":"2017","journal-title":"Theranostics"},{"issue":"7","key":"10.1016\/j.jcyt.2025.102009_bib0038","doi-asserted-by":"crossref","first-page":"1656","DOI":"10.1016\/j.transproceed.2017.03.078","article-title":"Thromboembolism Induced by Umbilical Cord Mesenchymal Stem Cell Infusion: A Report of Two Cases and Literature Review","volume":"49","author":"Wu","year":"2017","journal-title":"Transplant Proc"},{"issue":"1 Pt A","key":"10.1016\/j.jcyt.2025.102009_bib0039","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1016\/j.jcin.2014.07.023","article-title":"Angioplasty of femoral-popliteal arteries with drug-coated balloons: 5-year follow-up of the THUNDER trial","volume":"8","author":"Tepe","year":"2015","journal-title":"JACC Cardiovasc Interv"},{"key":"10.1016\/j.jcyt.2025.102009_bib0040","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1093\/bmb\/ldt009","article-title":"Coronary stents: historical development, current status and future directions","volume":"106","author":"Iqbal","year":"2013","journal-title":"Br Med Bull"},{"issue":"21","key":"10.1016\/j.jcyt.2025.102009_bib0041","doi-asserted-by":"crossref","first-page":"2170","DOI":"10.1001\/jama.2020.5697","article-title":"Association Between Thrombolytic Door-to-Needle Time and 1-Year Mortality and Readmission in Patients With Acute Ischemic Stroke","volume":"323","author":"Man","year":"2020","journal-title":"JAMA"},{"issue":"3","key":"10.1016\/j.jcyt.2025.102009_bib0042","doi-asserted-by":"crossref","first-page":"H550","DOI":"10.1152\/ajpheart.00183.2018","article-title":"No-reflow phenomenon in the heart and brain","volume":"315","author":"Kloner","year":"2018","journal-title":"Am J Physiol Heart Circ Physiol"},{"issue":"5","key":"10.1016\/j.jcyt.2025.102009_bib0043","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1007\/s10557-019-06901-0","article-title":"Pathophysiology, Diagnosis, and Management of the No-Reflow Phenomenon","volume":"33","author":"Allencherril","year":"2019","journal-title":"Cardiovasc Drugs Ther"},{"issue":"13","key":"10.1016\/j.jcyt.2025.102009_bib0044","doi-asserted-by":"crossref","first-page":"2077","DOI":"10.3390\/cells11132077","article-title":"Universal or Personalized Mesenchymal Stem Cell Therapies: Impact of Age, Sex, and Biological Source","volume":"11","author":"Carp","year":"2022","journal-title":"Cells"},{"key":"10.1016\/j.jcyt.2025.102009_bib0045","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1007\/978-1-4939-9086-3_1","article-title":"The Applicability of Mouse Models to the Study of Human Disease","volume":"1940","author":"Rydell-Tormanen","year":"2019","journal-title":"Methods Mol Biol"},{"issue":"1","key":"10.1016\/j.jcyt.2025.102009_bib0046","doi-asserted-by":"crossref","first-page":"e2062","DOI":"10.1038\/cddis.2015.327","article-title":"Mesenchymal stem cells and immunomodulation: current status and future prospects","volume":"7","author":"Gao","year":"2016","journal-title":"Cell Death Dis"},{"issue":"10","key":"10.1016\/j.jcyt.2025.102009_bib0047","doi-asserted-by":"crossref","first-page":"1939","DOI":"10.1111\/cas.13334","article-title":"Double-edged sword of mesenchymal stem cells: Cancer-promoting versus therapeutic potential","volume":"108","author":"Lee","year":"2017","journal-title":"Cancer Sci"},{"issue":"22","key":"10.1016\/j.jcyt.2025.102009_bib0048","doi-asserted-by":"crossref","DOI":"10.3390\/ijms222212429","article-title":"Mesenchymal Stem Cell: A Friend or Foe in Anti-Tumor Immunity","volume":"22","author":"Harrell","year":"2021","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.jcyt.2025.102009_bib0049","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/j.biochi.2022.05.019","article-title":"Pigment epithelium-derived factor and its role in microvascular-related diseases","volume":"200","author":"Wang","year":"2022","journal-title":"Biochimie"},{"issue":"14","key":"10.1016\/j.jcyt.2025.102009_bib0050","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1167\/iovs.65.14.41","article-title":"Functional Roles of Pigment Epithelium-Derived Factor in Retinal Degenerative and Vascular Disorders: A Scoping Review","volume":"65","author":"Jakobsen","year":"2024","journal-title":"Invest Ophthalmol Vis Sci"}],"container-title":["Cytotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1465324925009041?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1465324925009041?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,6,13]],"date-time":"2026-06-13T07:16:14Z","timestamp":1781334974000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1465324925009041"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2]]},"references-count":50,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2026,2]]}},"alternative-id":["S1465324925009041"],"URL":"https:\/\/doi.org\/10.1016\/j.jcyt.2025.102009","relation":{},"ISSN":["1465-3249"],"issn-type":[{"value":"1465-3249","type":"print"}],"subject":[],"published":{"date-parts":[[2026,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Implantation of human mesenchymal stromal cell pellet for therapeutic angiogenesis","name":"articletitle","label":"Article Title"},{"value":"Cytotherapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jcyt.2025.102009","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 International Society for Cell & Gene Therapy. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"102009"}}